Published in Ann Surg on August 01, 2006
Photodynamic therapy of cancer: an update. CA Cancer J Clin (2011) 6.08
Cholangiocarcinoma--controversies and challenges. Nat Rev Gastroenterol Hepatol (2011) 2.11
Intrabiliary RF heat-enhanced local chemotherapy of a cholangiocarcinoma cell line: monitoring with dual-modality imaging--preclinical study. Radiology (2013) 1.56
Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study. Gut Liver (2009) 1.43
Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr (2014) 1.18
Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer. Aliment Pharmacol Ther (2011) 1.06
Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients. World J Surg (2012) 1.04
Long-term outcome and prognostic factors of patients with hilar cholangiocarcinoma. World J Gastroenterol (2007) 1.03
Photodynamic therapy for unresectable cholangiocarcinoma. Dig Dis Sci (2011) 1.00
Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma. HPB (Oxford) (2009) 0.98
Chemoradiation in patients with unresectable extrahepatic and hilar cholangiocarcinoma or at high risk for disease recurrence after resection : Analysis of treatment efficacy and failure in patients receiving postoperative or primary chemoradiation. Strahlenther Onkol (2012) 0.96
Advances in endoscopic retrograde cholangiopancreatography for the treatment of cholangiocarcinoma. World J Gastrointest Endosc (2015) 0.89
Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cure. Int J Colorectal Dis (2014) 0.88
R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer. Liver Int (2010) 0.88
Outcome of surgical resection in Klatskin tumors. World J Gastrointest Oncol (2013) 0.88
Differentiation of malignant and benign proximal bile duct strictures: the diagnostic dilemma. World J Gastroenterol (2008) 0.88
Bilateral metallic stenting in malignant hilar obstruction. Clin Endosc (2014) 0.88
Inhibition of histone deacetylase for the treatment of biliary tract cancer: a new effective pharmacological approach. World J Gastroenterol (2007) 0.87
Update on the management of cholangiocarcinoma. Dig Dis (2014) 0.87
A patient with cholangiocarcinoma demonstrating pathologic complete response to chemotherapy: exploring the role of neoadjuvant therapy in biliary tract cancer. J Gastrointest Oncol (2014) 0.87
Evolution of the surgical management of perihilar cholangiocarcinoma in a Western centre demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion. HPB (Oxford) (2011) 0.86
Endomicroscopy in bile duct: Inflammation interferes with pCLE applied in the bile duct: A prospective study of 54 patients. United European Gastroenterol J (2013) 0.85
Photodynamic therapy: Palliation and endoscopic technique in cholangiocarcinoma. World J Gastrointest Endosc (2010) 0.85
Current status of photodynamic therapy for bile duct cancer. Clin Endosc (2013) 0.85
Safety and long term efficacy of porfimer sodium photodynamic therapy in locally advanced biliary tract carcinoma. Photodiagnosis Photodyn Ther (2012) 0.85
MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines. Int J Mol Sci (2014) 0.84
Molecular biomarkers in extrahepatic bile duct cancer patients undergoing chemoradiotherapy for gross residual disease after surgery. Radiat Oncol J (2012) 0.84
Advances in the management of biliary tract cancers. Clin Adv Hematol Oncol (2013) 0.84
Therapeutical concepts and results for Klatskin tumors. Dtsch Arztebl Int (2008) 0.83
Neoadjuvant therapy for downstaging of locally advanced hilar cholangiocarcinoma: a systematic review. HPB (Oxford) (2013) 0.83
Dual roles of nitric oxide in the regulation of tumor cell response and resistance to photodynamic therapy. Redox Biol (2015) 0.83
Photodynamic therapy for cholangiocarcinoma. Gut Liver (2010) 0.82
How to access photodynamic therapy for bile duct carcinoma. Ann Transl Med (2014) 0.82
Feasibility and safety of long-term photodynamic therapy (PDT) in the palliative treatment of patients with hilar cholangiocarcinoma. Eur J Med Res (2011) 0.82
The associated expression of Maspin and Bax proteins as a potential prognostic factor in intrahepatic cholangiocarcinoma. BMC Cancer (2006) 0.82
Photodynamic therapy of cholangiocarcinoma. HPB (Oxford) (2008) 0.82
Endoscopic management of hilar biliary strictures. World J Gastrointest Endosc (2015) 0.81
Photodynamic therapy in unresectable cholangiocarcinoma: not for the uncommitted. Clin Endosc (2013) 0.81
Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma. United European Gastroenterol J (2016) 0.81
Detection of benign hilar bile duct stenoses - A retrospective analysis in 250 patients with suspicion of Klatskin tumour. Ann Med Surg (Lond) (2016) 0.78
What are the current and potential future roles for endoscopic ultrasound in the treatment of pancreatic cancer? World J Gastrointest Endosc (2016) 0.78
Current status of photodynamic therapy in digestive tract carcinoma in Japan. Int J Mol Sci (2015) 0.78
Self-expandable metal stents and trans-stent light delivery: are metal stents and photodynamic therapy compatible? Lasers Surg Med (2008) 0.78
Guidelines for palliative surgery of cholangiocarcinoma. HPB (Oxford) (2008) 0.78
Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma: A systematic review and meta-analysis. World J Gastroenterol (2017) 0.78
The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade? World J Surg (2015) 0.78
Endoscopic management of hilar cholangiocarcinoma. Nat Rev Gastroenterol Hepatol (2012) 0.77
Treatment of hilar cholangiocarcinoma of Bismuth-Corlette type III with hepaticojejunostomy. Contemp Oncol (Pozn) (2013) 0.77
Local surgical resection of hilar cholangiocarcinoma: is there still a place? HPB (Oxford) (2008) 0.76
Multimodal treatment strategies for advanced hilar cholangiocarcinoma. Langenbecks Arch Surg (2014) 0.76
Biliary drainage strategy of unresectable malignant hilar strictures by computed tomography volumetry. World J Gastroenterol (2015) 0.76
Neoadjuvant Down-Sizing of Hilar Cholangiocarcinoma with Photodynamic Therapy-Long-Term Outcome of a Phase II Pilot Study. Int J Mol Sci (2015) 0.76
Reversal of jaundice in two patients with inoperable cholangiocarcinoma treated with Cisplatin and gemcitabine combination. Case Reports Hepatol (2012) 0.75
Clinical features and survival outcome of locally advanced extrahepatic cholangiocarcinoma. Korean J Hepatobiliary Pancreat Surg (2014) 0.75
Addition of hepatectomy decreases liver recurrence and leads to long survival in hilar cholangiocarcinoma. World J Gastroenterol (2009) 0.75
Is an aggressive surgical approach worthwhile in biliary cancer? Int Semin Surg Oncol (2007) 0.75
Is There Any Evidence for a Role of Local Treatment in Cholangiocarcinoma? Viszeralmedizin (2014) 0.75
Application of photodynamic therapy in gastrointestinal disorders: an outdated or re-emerging technique? Korean J Intern Med (2017) 0.75
Unilateral multiple metallic stent-in-stent for a case of hilar biliary cancer: an alternative stenting strategy. Saudi J Gastroenterol (2014) 0.75
Low rate of active treatment of patients with hilar cholangiocarcinoma. Ann R Coll Surg Engl (2013) 0.75
Emerging local ablative therapies for unresectable perihilar cholangiocarinoma: Time for re-appraisal. United European Gastroenterol J (2017) 0.75
Photodynamic therapy for biliary tract organ via a novel ultra-small composite optical fiberscope. Exp Ther Med (2017) 0.75
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg (2001) 5.94
Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg (1996) 5.42
Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet (1975) 4.17
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut (2002) 4.01
Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology (2003) 3.93
Extended resections for hilar cholangiocarcinoma. Ann Surg (1999) 2.93
Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc (2001) 2.90
Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg (1998) 2.81
Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg (1996) 2.54
Recent advances in the management of cholangiocarcinomas. Semin Liver Dis (1994) 2.30
Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg (1995) 2.28
Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg (1999) 2.24
A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol (2004) 2.23
A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc (1998) 2.21
Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol (1997) 2.16
Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc (1998) 2.05
Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg (2003) 2.04
Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg (2003) 2.03
Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg (2003) 2.00
Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg (2001) 1.99
Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg (2004) 1.99
"Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc (1995) 1.97
Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology (1998) 1.86
Surgical management of hilar cholangiocarcinoma. Ann Surg (2005) 1.80
Improved survival in resected biliary malignancies. Surgery (2002) 1.67
A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. Clin Gastroenterol Hepatol (2004) 1.66
Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage. Gastrointest Endosc (1988) 1.59
Radical resection of hilar bile duct carcinoma and predictors of survival. Br J Surg (2000) 1.57
Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma--a single center experience. Surgery (2000) 1.55
Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study. Gastrointest Endosc (2003) 1.50
Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg (2005) 1.49
Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery (1998) 1.47
Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion. Gut (1991) 1.47
Endoscopic retrograde forceps biopsy and brush cytology of biliary strictures: a prospective study. Gastrointest Endosc (1995) 1.46
What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer (1997) 1.43
Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology (2000) 1.43
Forceps biopsy and brush cytology during endoscopic retrograde cholangiopancreatography for the diagnosis of biliary stenoses. Scand J Gastroenterol (1997) 1.37
Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study. Cancer (2003) 1.35
Risk factors and classification of acute suppurative cholangitis. Br J Surg (1992) 1.28
Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma. Gastrointest Endosc (2003) 1.27
Endoscopic retrograde cholangiopancreatography and endoscopic endoprosthesis insertion in patients with Klatskin tumors. Arch Surg (1998) 1.21
Endoscopic transpapillary bile duct biopsy without sphincterotomy for diagnosing biliary strictures: a prospective comparative study with bile and brush cytology. Am J Gastroenterol (1996) 1.20
Photodynamic therapy to treat tumors of the extrahepatic biliary ducts. A case report. Arch Surg (1991) 1.17
Endoscopic application of photodynamic therapy for cholangiocarcinoma. Gastrointest Endosc (2001) 1.14
Management of malignant hilar biliary obstruction by endoscopy. Results and prognostic factors. Dig Dis Sci (1992) 1.10
Endoscopic transpapillary biopsy for diagnosis of patients with pancreaticobiliary ductal strictures. Am J Gastroenterol (1993) 1.09
Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg (2003) 1.08
Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase II study. Gastrointest Endosc (2004) 1.08
Liver resection for hilar cholangiocarcinoma: in-hospital mortality and longterm survival. J Am Coll Surg (2002) 0.97
A comparison of right versus left hepatic duct endoprosthesis insertion in malignant hilar biliary obstruction. Endoscopy (1989) 0.96
Neoadjuvant photodynamic therapy before curative resection of proximal bile duct carcinoma. J Hepatol (2000) 0.95
Extrahepatic bile duct resection in combination with liver resection for hilar cholangiocarcinoma: a report of 42 cases. J Gastrointest Surg (2004) 0.93
Photodynamic therapy for palliation of nonresectable bile duct cancer--preliminary results with a new diode laser system. Am J Gastroenterol (2001) 0.93
Promoter methylation of INK4a/ARF as detected in bile-significance for the differential diagnosis in biliary disease. Clin Cancer Res (2003) 0.90
Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med (2004) 25.68
Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med (2010) 8.40
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol (2005) 6.00
Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol (2012) 5.41
Lyme borreliosis. Lancet Infect Dis (2003) 4.58
Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J Immunol (2006) 4.04
Esophageal perforation during left atrial radiofrequency ablation: Is the risk too high? J Thorac Cardiovasc Surg (2003) 4.03
Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology (2003) 3.93
Diagnosis and phenotypic classification of Wilson disease. Liver Int (2003) 3.63
Wireless capsule endoscopy for diagnosis of acute intestinal graft-versus-host disease. Gastrointest Endosc (2007) 2.27
Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO/ARO/AIO-94. Int J Radiat Oncol Biol Phys (2006) 2.26
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Eur Urol (2007) 2.21
Complicated small-bowel diverticulosis: a case report and review of the literature. World J Gastroenterol (2007) 2.20
Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron (2003) 2.19
Complete resection in lung cancer surgery: proposed definition. Lung Cancer (2005) 2.12
p16, p14, p53, and cyclin D1 expression and HPV analysis in small cell carcinomas of the uterine cervix. Int J Gynecol Pathol (2006) 2.04
Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease: A randomized, sham-controlled trial. Gastroenterology (2006) 1.94
TFAP2E-DKK4 and chemoresistance in colorectal cancer. N Engl J Med (2012) 1.94
Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues. Clin Chem (2008) 1.87
Defective cellular localization of mutant ATP7B in Wilson's disease patients and hepatoma cell lines. Gastroenterology (2003) 1.86
Functional assessment of pancreatic beta-cell area in humans. Diabetes (2009) 1.82
Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial. Ann Surg (2007) 1.79
Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis. Hepatology (2013) 1.78
Partial pancreatectomy in adult humans does not provoke beta-cell regeneration. Diabetes (2007) 1.78
Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health. Dtsch Arztebl Int (2013) 1.72
Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Virchows Arch (2011) 1.72
Oral cancer diagnosis by mechanical phenotyping. Cancer Res (2009) 1.70
IgG4-related autoimmune diseases: Polymorphous presentation complicates diagnosis and treatment. Dtsch Arztebl Int (2015) 1.70
Inhibition of heme oxygenase 1 expression by small interfering RNA decreases orthotopic tumor growth in livers of mice. Int J Cancer (2008) 1.68
Diverse functional properties of Wilson disease ATP7B variants. Gastroenterology (2012) 1.61
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
Epigenetic silencing of the PTEN gene in melanoma. Cancer Res (2006) 1.58
Self-expandable metallic stents for malignant duodenal obstruction caused by biliary tract cancer. Gastrointest Endosc (2003) 1.57
SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. Oncogene (2005) 1.55
Norepinephrine-induced changes in cardiac transforming growth factor-beta isoform expression pattern of female and male rats. Hypertension (2004) 1.50
Endoscopic full-thickness plication for the treatment of GERD by application of multiple Plicator implants: a multicenter study (with video). Gastrointest Endosc (2008) 1.48
Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma. Int J Cancer (2011) 1.47
Significant value of autopsy for quality management in cardiac surgery. J Thorac Cardiovasc Surg (2005) 1.45
Assay-based response evaluation in head and neck oncology: requirements for better decision making. Eur Arch Otorhinolaryngol (2010) 1.44
Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. J Clin Oncol (2003) 1.44
ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma. BMC Cancer (2009) 1.44
Quality of life of colorectal cancer patients in certified centers versus non-certified hospitals. Onkologie (2012) 1.41
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. Eur Urol (2007) 1.37
Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol (2005) 1.37
[18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors. Nucl Med Biol (2003) 1.36
Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study. Cancer (2003) 1.35
Caroli's disease: liver resection and liver transplantation. Experience in 33 patients. Surgery (2005) 1.34
Absence of mutations of the BRAF gene and constitutive activation of extracellular-regulated kinase in malignant melanomas of the uvea. Lab Invest (2003) 1.33
Determination of temperature elevation in tissue during the application of the harmonic scalpel. Ultrasound Med Biol (2003) 1.32
Mutations of the BRAF gene in squamous cell carcinoma of the head and neck. Oncogene (2003) 1.32
Endoscopic full-thickness resection and defect closure in the colon. Gastrointest Endosc (2010) 1.32
MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B. Lab Invest (2011) 1.30
Improving the TNM classification: findings from a 10-year continuous literature review. Int J Cancer (2014) 1.27
The second international conference on sentinel node biopsy in mucosal head and neck cancer. Ann Surg Oncol (2005) 1.26
The Endoscopic Treatment of Iatrogenic Gastrointestinal Perforation. Dtsch Arztebl Int (2016) 1.26
The diagnosis and treatment of cholangiocarcinoma. Dtsch Arztebl Int (2014) 1.25
Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer. Clin Cancer Res (2009) 1.25
Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. J Hepatol (2012) 1.23
Genetic regulation of serum phytosterol levels and risk of coronary artery disease. Circ Cardiovasc Genet (2010) 1.23
Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness. J Hepatol (2006) 1.22
Unchanged high mortality rates from acute occlusive intestinal ischemia: six year review. Langenbecks Arch Surg (2008) 1.21
On the use and abuse of X in the TNM classification. Cancer (2005) 1.21
Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours. J Hepatol (2009) 1.21
Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma. Int J Cancer (2012) 1.18
Endoscopic radiofrequency ablation for malignant biliary obstruction: a nationwide retrospective study of 84 consecutive applications. Surg Endosc (2013) 1.17
Endoscopic closure of duodenal perforations by using an over-the-scope clip: a randomized, controlled porcine study. Gastrointest Endosc (2009) 1.17
Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis. Virchows Arch (2002) 1.15
Pancreatic neuroendocrine tumor with ectopic adrenocorticotropin production upon second recurrence. J Clin Endocrinol Metab (2004) 1.14
Ductal pancreatic adenocarcinoma. Dtsch Arztebl Int (2014) 1.14
Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride. Cancer Chemother Pharmacol (2006) 1.13
Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors. Int J Cancer (2005) 1.13
Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays. J Pathol (2003) 1.12